RGD Reference Report - Generation of immunodeficient rats with Rag1 and Il2rg gene deletions and human tissue grafting models. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

Generation of immunodeficient rats with Rag1 and Il2rg gene deletions and human tissue grafting models.

Authors: Ménoret, Séverine  Ouisse, Laure-Hélène  Tesson, Laurent  Delbos, Frédéric  Garnier, Delphine  Remy, Séverine  Usal, Claire  Concordet, Jean-Paul  Giovannangeli, Carine  Chenouard, Vanessa  Brusselle, Lucas  Merieau, Emmanuel  Nerrière-Daguin, Véronique  Duteille, Franck  Bellier-Waast, Frédérique  Fraichard, Alexandre  Nguyen, Tuan H  Anegon, Ignacio 
Citation: Ménoret S, etal., Transplantation. 2018 Apr 24. doi: 10.1097/TP.0000000000002251.
RGD ID: 13628403
Pubmed: PMID:29688994   (View Abstract at PubMed)
DOI: DOI:10.1097/TP.0000000000002251   (Journal Full-text)


BACKGROUND: Immunodeficient mice are invaluable tools to analyze the long-term effects of potentially immunogenic molecules in the absence of adaptive immune responses. Nevertheless, there are models and experimental situations that would beneficiate of larger immunodeficient recipients. Rats are ideally suited to perform experiments in which larger size is needed and are still a small animal model suitable for rodent facilities. Additionally, rats reproduce certain human diseases better than mice, such as ankylosing spondylitis and Duchenne disease and these disease models would greatly benefit of immunodeficient rats to test different immunogenic treatments.
METHODS: We describe the generation of Il2rg-deficient rats and their crossing with previously described Rag1-deficient rats to generate double-mutant RRG animals.
RESULTS: As compared to Rag1-deficient rats, Il2rg-deficient rats were more immunodeficient since partially lacked not only T and B cells but also NK cells. RRG animals showed a more profound immunossuppressed phenotype since they displayed undetectable levels of T, B and NK cells. Similarly, all immunoglobulin isotypes in sera were decreased in Rag1 or Il2rg-deficient rats and undetectable in RRG animals. Rag1 or Il2rg-deficient rats rejected allogeneic skin transplants and human tumors whereas RRG animals not only accepted allogeneic rat skin but also xenogeneic human tumors, skin and hepatocytes. Immune humanization of RRG animals was unsuccessful.
CONCLUSION: Thus, immunodeficient RRG animals are useful recipients for long term studies in which immune responses could be an obstacle, including tissue humanization of different tissues.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  

Phenotype Annotations    Click to see Annotation Detail View

Mammalian Phenotype

Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
Il2rgRatdecreased bone marrow cell number  IMP  RGD 
Il2rgem1AngRatdecreased bone marrow cell number  IMP  RGD 
Rag1Ratdecreased bone marrow cell number  IMP  RGD 
Rag1em1AngRatdecreased bone marrow cell number  IMP  RGD 
SD-Il2rgem1AngRatdecreased bone marrow cell number  IMP  RGD 
SD-Rag1em1AngRatdecreased bone marrow cell number  IMP  RGD 
Il2rgRatdecreased CD4-positive, alpha-beta T cell number  IMP  RGD 
Il2rgem1AngRatdecreased CD4-positive, alpha-beta T cell number  IMP  RGD 
Rag1Ratdecreased CD4-positive, alpha-beta T cell number  IMP  RGD 
Rag1em1AngRatdecreased CD4-positive, alpha-beta T cell number  IMP  RGD 
SD-Il2rgem1AngRatdecreased CD4-positive, alpha-beta T cell number  IMP  RGD 
SD-Rag1em1AngRatdecreased CD4-positive, alpha-beta T cell number  IMP  RGD 
Il2rgRatdecreased CD8-positive, alpha-beta T cell number  IMP  RGD 
Il2rgem1AngRatdecreased CD8-positive, alpha-beta T cell number  IMP  RGD 
Rag1Ratdecreased CD8-positive, alpha-beta T cell number  IMP  RGD 
Rag1em1AngRatdecreased CD8-positive, alpha-beta T cell number  IMP  RGD 
SD-Il2rgem1AngRatdecreased CD8-positive, alpha-beta T cell number  IMP  RGD 
SD-Rag1em1AngRatdecreased CD8-positive, alpha-beta T cell number  IMP  RGD 
Il2rgRatdecreased mature B cell number  IMP  RGD 
Il2rgem1AngRatdecreased mature B cell number  IMP  RGD 
Rag1Ratdecreased mature B cell number  IMP  RGD 
Rag1em1AngRatdecreased mature B cell number  IMP  RGD 
SD-Il2rgem1AngRatdecreased mature B cell number  IMP  RGD 
SD-Rag1em1AngRatdecreased mature B cell number  IMP  RGD 
Il2rgRatdecreased NK cell number  IMP  RGD 
Il2rgem1AngRatdecreased NK cell number  IMP  RGD 
Rag1Ratdecreased NK cell number  IMP  RGD 
Rag1em1AngRatdecreased NK cell number  IMP  RGD 
SD-Il2rgem1AngRatdecreased NK cell number  IMP  RGD 
SD-Rag1em1AngRatdecreased NK cell number  IMP  RGD 
Il2rgRatdecreased T cell number  IMP  RGD 
Il2rgem1AngRatdecreased T cell number  IMP  RGD 
SD-Il2rgem1AngRatdecreased T cell number  IMP  RGD 
Il2rgRatdecreased thymocyte number  IMP  RGD 
Il2rgem1AngRatdecreased thymocyte number  IMP  RGD 
Rag1Ratdecreased thymocyte number  IMP  RGD 
Rag1em1AngRatdecreased thymocyte number  IMP  RGD 
SD-Il2rgem1AngRatdecreased thymocyte number  IMP  RGD 
SD-Rag1em1AngRatdecreased thymocyte number  IMP  RGD 
Il2rgRatlymph node hypoplasia  IMP  RGD 
Il2rgem1AngRatlymph node hypoplasia  IMP  RGD 
Rag1Ratlymph node hypoplasia  IMP  RGD 
Rag1em1AngRatlymph node hypoplasia  IMP  RGD 
SD-Il2rgem1AngRatlymph node hypoplasia  IMP  RGD 
SD-Rag1em1AngRatlymph node hypoplasia  IMP  RGD 
Il2rgRatspleen hypoplasia  IMP  RGD 
Il2rgem1AngRatspleen hypoplasia  IMP  RGD 
Rag1Ratspleen hypoplasia  IMP  RGD 
Rag1em1AngRatspleen hypoplasia  IMP  RGD 
SD-Il2rgem1AngRatspleen hypoplasia  IMP  RGD 
SD-Rag1em1AngRatspleen hypoplasia  IMP  RGD 
Objects Annotated

Genes (Rattus norvegicus)
Il2rg  (interleukin 2 receptor subunit gamma)
Il2rgem1Ang  (interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang)
Rag1  (recombination activating 1)
Rag1em1Ang  (recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon)

Genes (Mus musculus)
Il2rg  (interleukin 2 receptor, gamma chain)
Rag1  (recombination activating 1)

Genes (Homo sapiens)
IL2RG  (interleukin 2 receptor subunit gamma)
RAG1  (recombination activating 1)

Strains
SD-Il2rgem1Ang  (NA)
SD-Rag1em1Ang  (NA)


Additional Information